Hem › Atopisk dermatit (eksem) › Alabama › Birmingham
Kliniska studier för Atopisk dermatit (eksem) i Birmingham, AL
9 studier för Atopisk dermatit (eksem) söker deltagare vid platser i och runt Birmingham (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
RekryterarObservationsstudie
- Cahaba Dermatology & Skin Health Center- Site Number : 8400006, Birmingham
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
RekryterarFas 2
- Novartis Investigative Site, Birmingham
- Novartis Investigative Site, Birmingham
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
RekryterarFas 3
- Cahaba Dermatology & Skin Health Center, Birmingham
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
RekryterarFas 2
- Enveda Investigative Site, Birmingham
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
RekryterarFas 1Friska volontärer välkomna
- Cahaba Dermatology & Skin Health Center, LLC, Birmingham
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
RekryterarFas 2
- AllerVie Clinical Research, Birmingham
- Cahaba Dermatology and Skin Health Center, Birmingham
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
RekryterarFas 3
- Leo Pharma Investigational site, Birmingham
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
RekryterarFas 3
- Cahaba Dermatology & Skin Health Center /ID# 263855, Birmingham
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
RekryterarFas 2
- Allervie Clinical Research, Birmingham
Atopisk dermatit (eksem)-studier i andra städer
- New York City, NY13 studier
- Los Angeles, CA11 studier
- Washington, DC11 studier
- San Antonio, TX10 studier
- San Diego, CA10 studier
- Miami, FL9 studier
- Dallas, TX8 studier
- Huntington Beach, CA8 studier
- Sacramento, CA8 studier
- Troy, MI8 studier
- Indianapolis, IN7 studier
- Pittsburgh, PA7 studier
Andra studier i Birmingham
- Cancer (alla typer)31 studier
- Bröstcancer24 studier
- Äggstockscancer23 studier
- Övervikt23 studier
- Icke-småcellig lungcancer22 studier
- Akut myeloid leukemi21 studier
- Multipelt myelom18 studier
- KOL17 studier
- Hjärt-kärlsjukdom17 studier
- Typ 2-diabetes16 studier
- Endometriecancer16 studier
- Övervikt16 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.